Increased Autoreactivity of the Complement-Activating Molecule Mannan-Binding Lectin in a Type 1 Diabetes Model

Figure 3

Plasma concentration of C3 in control and diabetic group with the within-group median indicated with X. (a) Total C3 concentration; value refers to Wilcoxon rank-sum test. (b) Complement activation product C3a concentration; value refers to Wilcoxon rank-sum test. (c) Ratio between plasma C3a and total plasma C3; NS refers to nonsignificant Wilcoxon rank-sum test.

(a)

(b)

(c)